Home
    Disclaimer
    4-Chloromethamphetamine molecular structure

    4-Chloromethamphetamine Stats & Data

    Chemical Class Amphetamine
    Psychoactive Class Stimulant
    Half-Life Unknown in humans (no validated PK). Animal and mechanistic literature focus on neurotoxicity rather than disposition; caution is warranted.

    Effect Profile

    Curated
    Stimulant 6.5

    Strong euphoria and anxiety/jitters with moderate focus and stimulation

    Stimulation / Energy×3
    6
    Euphoria / Mood Lift×2
    10
    Focus / Productivity×2
    7
    Anxiety / Jitters×1
    10

    Tolerance & Pharmacokinetics

    drugs.wiki
    Half-Life
    Unknown in humans (no validated PK). Animal and mechanistic literature focus on neurotoxicity rather than disposition; caution is warranted.
    Addiction Potential
    Habit-forming potential similar to other stimulants, but repeated/chronic use is self-limiting due to dysphoria and pronounced serotonergic toxicity.

    Tolerance Decay

    Full tolerance 2d Half tolerance 14d Baseline ~28d

    Quantitative tolerance data for 4-CMA do not exist. Timeline above is a conservative, low-confidence scaffold extrapolated from stimulant tolerance patterns and severe serotonergic disruption seen with PCA-class agents; prioritize long spacing (≥4 weeks) after any exposure to allow recovery. Data quality: anecdotal/theoretical.

    Cross-Tolerances

    Amphetamine derivatives (general)
    30% ●○○
    Other serotonergic releasers (e.g., MDMA/MDA)
    40% ●○○

    Harm Reduction

    drugs.wiki

    Reason for strong avoidance: para-Chloroamphetamine (4-CA, PCA) is a well-characterized, long-lasting serotonergic neurotoxin in animals; 4-CMA is the N-methyl analogue and likely undergoes N-dealkylation to 4-CA, so even single exposures may produce enduring serotonergic injury. Protective effects of SERT blockers and peripheral 5-HT depletion against PCA neurotoxicity indicate a serotonin-dependent toxic process, not merely acute depletion. In rats, PCA causes degeneration of serotonergic axons with persistent reductions in 5-HT, 5-HIAA, SERT, and tryptophan hydroxylase; some damage becomes irreversible 24–48 h post-dose. Therefore, redosing 4-CMA within a session or on consecutive days plausibly increases the chance that reversible depletion progresses toward axonal injury. In hot or high-exertion settings, serotonergic stimulants raise risk of hyperthermia; conversely, excessive water intake can cause hyponatremia. Safer-clubbing guidance recommends sipping about 250 mL/h at rest and up to ~500 mL/h when dancing, using electrolyte-containing fluids; avoid both dehydration and overhydration. Serotonin syndrome can occur when combining serotonergic agents (e.g., MAOIs, SSRIs/SNRIs, MDMA, DXM, tramadol); seek urgent care for agitation, clonus, tremor, hyperthermia, confusion. Community early warnings have documented vendors listing 4-CMA and calls to test suspect products; pills/crystals sold as other stimulants can contain unexpected chlorinated compounds—only laboratory drug checking definitively identifies 4-CMA. Multi-reagent kits (e.g., Marquis, Froehde, Simon’s, Zimmerman, Morris) help screen but are not definitive; treat unknowns as hazardous until lab-verified. Because of the high neurotoxicity signal from PCA and the plausible metabolic link, conservative harm reduction is to avoid use; if exposed, use the minimum possible dose, do not redose, and leave at least several weeks before any further serotonergic exposure. Those with cardiovascular disease, seizure disorders, or psychiatric vulnerability (anxiety, depression) may be at heightened risk of adverse outcomes. Women appear disproportionately represented in MDMA-related hyponatremia cases; similar caution applies to serotonergic stimulants. Maintain cool ambient temperature, take rest breaks, monitor for jaw tension, agitation, and overheating, and avoid polydrug use.

    ← Back to 4-Chloromethamphetamine